Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Acelyrin Inc (NASDAQ: SLRN) closed the day trading at $6.83 down -2.43% from the previous closing price of $7.00. In other words, the price has decreased by -$2.43 from its previous closing price. On the day, 1.2 million shares were traded. SLRN stock price reached its highest trading level at $7.08 during the session, while it also had its lowest trading level at $6.505.
Ratios:
For a better understanding of SLRN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.27 and its Current Ratio is at 13.27. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 13, 2023, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $11.
On December 08, 2023, Citigroup started tracking the stock assigning a Neutral rating and target price of $8.Citigroup initiated its Neutral rating on December 08, 2023, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 17 ’24 when Becker Daniel J. sold 1 shares for $6.86 per share. The transaction valued at 7 led to the insider holds 2,999 shares of the business.
Lin Shao-Lee sold 9,961 shares of SLRN for $66,024 on Apr 01 ’24. The Chief Executive Officer now owns 1,577,374 shares after completing the transaction at $6.63 per share. On Feb 20 ’24, another insider, Lin Shao-Lee, who serves as the Chief Executive Officer of the company, sold 15,701 shares for $7.60 each. As a result, the insider received 119,403 and left with 1,587,335 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLRN now has a Market Capitalization of 676354432 and an Enterprise Value of -819706.
Stock Price History:
Over the past 52 weeks, SLRN has reached a high of $29.88, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is 40.92%, while the 200-Day Moving Average is calculated to be 1.37%.
Shares Statistics:
Over the past 3-months, SLRN traded about 952.12K shares per day on average, while over the past 10 days, SLRN traded about 1278350 shares per day. A total of 97.87M shares are outstanding, with a floating share count of 62.84M. Insiders hold about 36.54% of the company’s shares, while institutions hold 75.72% stake in the company. Shares short for SLRN as of 1721001600 were 6807752 with a Short Ratio of 7.15, compared to 1718323200 on 6982265. Therefore, it implies a Short% of Shares Outstanding of 6807752 and a Short% of Float of 7.8600004000000006.
Earnings Estimates
The stock of Acelyrin Inc (SLRN) is currently drawing attention from 5.0 analysts actively involved in the ongoing evaluation and rating process.On average, analysts expect EPS of -$0.75 for the current quarter, with a high estimate of -$0.33 and a low estimate of -$1.03, while EPS last year was -$0.4. The consensus estimate for the next quarter is -$0.8, with high estimates of -$0.3 and low estimates of -$1.2.
Analysts are recommending an EPS of between -$1.26 and -$4.17 for the fiscal current year, implying an average EPS of -$2.94. EPS for the following year is -$3.79, with 5.0 analysts recommending between -$2.34 and -$5.23.
